nifedipine has been researched along with Diabetic Retinopathy in 4 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study if the endogenous renin-angiotensin system affects diabetic retinal leukostasis, rats with streptozotocin-induced diabetes were treated with an ACE inhibitor (ramipril), an angiotensin II AT(1) receptor antagonist (losartan) and the Ca channel blocker, (nifedipine)." | 7.73 | Role of angiotensin II in retinal leukostasis in the diabetic rat. ( Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM, 2006) |
| "To compare the effects of nifedipine and enalapril on carbohydrate and lipoprotein metabolism in Chinese non-insulin-dependent diabetes mellitus (NIDDM) patients with hypertension." | 5.07 | The effects of enalapril and nifedipine on carbohydrate and lipid metabolism in NIDDM. ( Chan, JC; Cockram, CS; Leung, DH; Nicholls, MG; Tomlinson, B; Yeung, VT, 1994) |
| "To study if the endogenous renin-angiotensin system affects diabetic retinal leukostasis, rats with streptozotocin-induced diabetes were treated with an ACE inhibitor (ramipril), an angiotensin II AT(1) receptor antagonist (losartan) and the Ca channel blocker, (nifedipine)." | 3.73 | Role of angiotensin II in retinal leukostasis in the diabetic rat. ( Chen, P; Dahl, D; Edwards, PA; Fenstermacher, JD; Guo, M; Scicli, AG; Scicli, GM, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oraebosi, MI | 1 |
| Olurishe, TO | 1 |
| Anafi, SB | 1 |
| Bisalla, M | 1 |
| Yamagishi, S | 1 |
| Chen, P | 1 |
| Scicli, GM | 1 |
| Guo, M | 1 |
| Fenstermacher, JD | 1 |
| Dahl, D | 1 |
| Edwards, PA | 1 |
| Scicli, AG | 1 |
| Chan, JC | 1 |
| Yeung, VT | 1 |
| Leung, DH | 1 |
| Tomlinson, B | 1 |
| Nicholls, MG | 1 |
| Cockram, CS | 1 |
1 review available for nifedipine and Diabetic Retinopathy
| Article | Year |
|---|---|
[Calcium antagonists: current and future applications based on new evidence. Calcium antagonists and diabetes].
Topics: Antioxidants; Calcium Channel Blockers; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Reti | 2010 |
1 trial available for nifedipine and Diabetic Retinopathy
| Article | Year |
|---|---|
The effects of enalapril and nifedipine on carbohydrate and lipid metabolism in NIDDM.
Topics: Apolipoprotein A-I; Apolipoproteins B; Biomarkers; Blood Glucose; Blood Pressure; China; Cholesterol | 1994 |
2 other studies available for nifedipine and Diabetic Retinopathy
| Article | Year |
|---|---|
Chronopharmacology of the alpha-lipoic acid/nifedipine/glimepiride combination in the amelioration of retinopathy in rats.
Topics: Animals; Antioxidants; Circadian Rhythm; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Nife | 2021 |
Role of angiotensin II in retinal leukostasis in the diabetic rat.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; A | 2006 |